Cargando…
Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
INTRODUCTION: FIGO 2018 IIIC remains controversial for the heterogeneity of its prognoses. To ensure a better management of cervical cancer patients in Stage IIIC, a revision of the FIGO IIIC version classification is required according to local tumor size. MATERIAL AND METHODS: We retrospectively e...
Autores principales: | Duan, Hui, Li, Huimin, Kang, Shan, Zhao, Hongwei, Chen, Biliang, Wang, Li, Li, Pengfei, Wang, Yahong, Wang, Wei, Lang, Jinghe, Liu, Ping, Chen, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378020/ https://www.ncbi.nlm.nih.gov/pubmed/37338046 http://dx.doi.org/10.1111/aogs.14612 |
Ejemplares similares
-
Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022) -
Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study
por: Ye, Yanna, et al.
Publicado: (2023) -
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023) -
Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022) -
Validation of the 2018 FIGO Staging System for Predicting the
Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)